Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial

The Lancet

Volumn 389, Issue 10076, 2017, Pages 1299-1311

  Atkin, Wendy ^a   Wooldrage, Kate ^a   Parkin, D Maxwell ^b   Kralj Hans, Ines ^a   MacRae, Eilidh ^a   Shah, Urvi ^a   Duffy, Stephen ^c   Cross, Amanda J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCENDING COLON; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGMOIDOSCOPY; UNITED KINGDOM; CLINICAL TRIAL; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; INCIDENCE; MASS SCREENING; MORTALITY; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; SIGMOIDOSCOPY; TIME FACTORS; UNITED KINGDOM;

EID: 85013422810     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)30396-3     Document Type: Article

References (20)

1. 1 Atkin, WS, Cook, CF, Cuzick, J, et al. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359 (2002), 1291–1300.
2. 2 Atkin, WS, Edwards, R, Kralj-Hans, I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (2010), 1624–1633.
3. 3 Segnan, N, Armaroli, P, Bonelli, L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 103 (2011), 1310–1322.
4. 4 Holme, Ø, Løberg, M, Kalager, M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 312 (2014), 606–615.
5. 5 Mayor, S, UK committee recommends flexible sigmoidoscopy to screen for bowel cancer. BMJ, 342, 2011, d2325.
6. 6 National Cancer Intelligence Network. Older people and cancer, 2014, Public Health England, London.
7. 7 Atkin, WS, Edwards, R, Wardle, J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 8 (2001), 137–144.
8. 8 Atkin, WS, Cuzick, J, Northover, JM, Whynes, DK, Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341 (1993), 736–740.
9. 9 Turner, EL, Metcalfe, C, Donovan, JL, et al. Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee. Br J Cancer 115 (2016), 90–94.
10. 10 Cuzick, J, Cafferty, FH, Edwards, R, Moller, H, Duffy, SW, Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen 14 (2007), 178–185.
11. 11 Cuzick, J, Edwards, R, Segnan, N, Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 16 (1997), 1017–1029.
12. 12 Tabar, L, Vitak, B, Yen, MF, Chen, HH, Smith, RA, Duffy, SW, Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen 11 (2004), 126–129.
13. 13 Schoen, RE, Pinsky, PF, Weissfeld, JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366 (2012), 2345–2357.
14. 14 Office for National Statistics. Cancer Registration Statistics, England, 1998–2014. http://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancerregistrationstatisticscancerregistrationstatisticsengland (accessed Dec 6, 2016).
15. 15 Nishihara, R, Wu, K, Lochhead, P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
16. 16 Siegel, RL, Ward, EM, Jemal, A, Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992–2008. Cancer Epidemiol Biomarkers Prev 21 (2012), 411–416.
17. 17 Imperiale, TF, Ransohoff, DF, Itzkowitz, SH, Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 371 (2014), 187–188.
18. 18 Hirai, HW, Tsoi, KK, Chan, JY, et al. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Aliment Pharmacol Ther 43 (2016), 755–764.
19. 19 Troy Brown, RN, FDA panel recommends new colon cancer test by narrow margin. http://www.medscape.com/viewarticle/822659, March 26, 2014 (accessed Jan 12, 2017).
20. 20 Holme, O, Schoen, RE, Senore, C, et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ, 356, 2017, i6673.